All Journal Entries Journals
Previous | Next

Prostate Biopsy -- Risks Outweigh Benefits.

Oct 06, 2015 - 0 comments
Tags:

Prostate biopsy

,

septicaemia

,

mortality rate



It depends on what study you wish to quote but all studies into the risks of prostate biopsy show that it does have a mortality rate. A met-analysis of these studies would probably come up with a figure of about 1% mortality from prostate biopsy. Most of these deaths are as a result of septicemia. In order to reach the prostate with a biopsy needle the operator must pass the needle through the rectal wall. This is an area of known bacterial growth - hence the infection.

If as appears to be the case, prostate biopsy carries a significant mortality rate then it can be argued that the risks outweigh the potential benefits. Have a listen to this:  http://www.medscape.com/viewarticle/805575

Post a Comment